NIDA’s Clinical Trials Network: An Opportunity for HIV Research in Community Substance Abuse Treatment Programs

Background/Objectives: HIV continues to be a significant problem among substance users and their sexual partners in the United States. The National Drug Abuse Treatment Clinical Trials Network (CTN) offers a national platform for effectiveness trials of HIV interventions in community substance abuse treatment programs. This article presents the HIV activities of the CTN during its first 10 years. Results: While emphasizing CTN HIV protocols, this article reviews the (1) HIV context for this work; (2) the collaborative process among providers, researchers, and National Institute on Drug Abuse CTN staff, on which CTN HIV work was based; (3) results of CTN HIV protocols and HIV secondary analyses in CTN non-HIV protocols; and (4) implications for future HIV intervention effectiveness research in community substance abuse treatment programs. Conclusion/Significance: While the feasibility of engaging frontline providers in this research is highlighted, the limitations of small to medium effect sizes and weak adoption and sustainability in everyday practice are also discussed.

[1]  G. Lucas.  Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals. , 2011, Life sciences.

[2]  N. Volkow,et al.  Prevention and treatment of HIV/AIDS among drug-using populations: a global perspective. , 2010, Journal of acquired immune deficiency syndromes.

[3]  G. Woody,et al.  Drug Treatment as HIV Prevention: A Research Update , 2010, Journal of Acquired Immune Deficiency Syndromes.

[4]  J. Potter,et al.  Gender Differences in the Rates and Correlates of HIV Risk Behaviors Among Drug Abusers , 2010, Substance use & misuse.

[5]  E. Vittinghoff,et al.  Amphetamine-group substances and HIV , 2010, The Lancet.

[6]  D. McCarty,et al.  The first decade of the National Drug Abuse Treatment Clinical Trials Network: bridging the gap between research and practice to improve drug abuse treatment. , 2010, Journal of substance abuse treatment.

[7]  Richard D Moore,et al.  Clinic-Based Treatment of Opioid-Dependent HIV-Infected Patients Versus Referral to an Opioid Treatment Program , 2010, Annals of Internal Medicine.

[8]  H. Pollack,et al.  HIV testing and counseling in the nation's outpatient substance abuse treatment system, 1995-2005. , 2010, Journal of substance abuse treatment.

[9]  N. Volkow,et al.  Enhanced HIV testing, treatment, and support for HIV-infected substance users. , 2010, JAMA.

[10]  H. Jiang,et al.  The Impact of Trauma-Focused Group Therapy upon HIV Sexual Risk Behaviors in the NIDA Clinical Trials Network “Women and Trauma” Multi-Site Study , 2010, AIDS and Behavior.

[11]  Stephen Pilling,et al.  Psychosocial interventions for reducing injection and sexual risk behaviour for preventing HIV in drug users. , 2010, The Cochrane database of systematic reviews.

[12]  J. Harrer,et al.  Motivational and skills training HIV/sexually transmitted infection sexual risk reduction groups for men. , 2009, Journal of substance abuse treatment.

[13]  Robert Sage,et al.  Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. , 2009, Journal of consulting and clinical psychology.

[14]  A. Fauci,et al.  Universal voluntary testing and treatment for prevention of HIV transmission. , 2009, JAMA.

[15]  E. Bini,et al.  Disparities in Health Services for HIV/AIDS, Hepatitis C Virus, and Sexually Transmitted Infections: Role of Substance Abuse Treatment Programs , 2009, Journal of addiction medicine.

[16]  C. del Rio,et al.  Hospitalized HIV-infected patients in the era of highly active antiretroviral therapy. , 2009, American journal of public health.

[17]  D. McCarty,et al.  Facilitating outpatient treatment entry following detoxification for injection drug use: a multisite test of three interventions. , 2009, Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors.

[18]  Christopher Dye,et al.  Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model , 2009, The Lancet.

[19]  K. Dugosh,et al.  Extended vs. short‐term buprenorphinenaloxone for treatment of opioid addicted youth: A randomized trial , 2008, JAMA.

[20]  Mei-Chen Hu,et al.  Effectiveness of HIV/STD Sexual Risk Reduction Groups for Women in Substance Abuse Treatment Programs: Results of NIDA Clinical Trials Network Trial , 2008, Journal of acquired immune deficiency syndromes.

[21]  B. Yip,et al.  Highly active antiretroviral therapy and survival in HIV-infected injection drug users. , 2008, JAMA.

[22]  D. D. Des Jarlais,et al.  HIV prevention for injecting drug users: the first 25 years and counting. , 2008, Psychosomatic medicine.

[23]  E. Bini,et al.  States and substance abuse treatment programs: funding and guidelines for infection-related services. , 2008, American journal of public health.

[24]  D. D. Des Jarlais,et al.  Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug. , 2008, The International journal on drug policy.

[25]  E. Bini,et al.  Health Services for HIV/AIDS, HCV, and Sexually Transmitted Infections in Substance Abuse Treatment Programs , 2007, Public health reports.

[26]  C. Leukefeld,et al.  HIV testing in correctional agencies and community treatment programs: the impact of internal organizational structure. , 2007, Journal of substance abuse treatment.

[27]  H. Wexler,et al.  National Criminal Justice Drug Abuse Treatment Studies (CJ-DATS) Overview , 2007 .

[28]  J. Guydish,et al.  Strategies to encourage adoption in multisite clinical trials. , 2007, Journal of substance abuse treatment.

[29]  A. Abdul-Quader,et al.  Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City , 2007, AIDS.

[30]  Declan T. Barry,et al.  A trial of integrated buprenorphine/naloxone and HIV clinical care. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  Atlanta,et al.  Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. , 2006, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[32]  Blair T. Johnson,et al.  Behavioral HIV risk reduction among people who inject drugs: meta-analytic evidence of efficacy. , 2006, Journal of substance abuse treatment.

[33]  Evan Wood,et al.  The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic , 2006, The Lancet.

[34]  M. Swartz,et al.  Barriers to antiretroviral adherence: the importance of depression, abuse, and other traumatic events. , 2006, AIDS patient care and STDs.

[35]  E. Bini,et al.  Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: the National Drug Abuse Treatment Clinical Trials Network. , 2006, Journal of substance abuse treatment.

[36]  A. Wodak,et al.  Effectiveness of sterile needle and syringe programmes , 2005 .

[37]  S. Shoptaw,et al.  The methamphetamine epidemic: Implications for HIV prevention and treatment , 2005, Current HIV/AIDS reports.

[38]  C. Malotte,et al.  Relative Efficacy of Prevention Counseling With Rapid and Standard HIV Testing: A Randomized, Controlled Trial (RESPECT-2) , 2005, Sexually transmitted diseases.

[39]  W. Bickel,et al.  Efficacy of computer-based HIV/AIDS education for injection drug users. , 2004, American journal of health behavior.

[40]  Z. Vassilev,et al.  On-Site HIV Testing in Residential Drug Treatment Units: Results of a Nationwide Survey , 2003, Public health reports.

[41]  C. Leukefeld,et al.  Women, sex, and HIV: social and contextual factors, meta-analysis of published interventions, and implications for practice and research. , 2002, Psychological bulletin.

[42]  J. Sigmund.  Seeking Safety: A Treatment Manual for PTSD and Substance Abuse , 2002 .

[43]  A. Leshner,et al.  Putting drug abuse research to use in real-life settings. , 2002, Journal of substance abuse treatment.

[44]  J. Sorensen,et al.  HIV/Hepatitis Prevention in Drug Abuse Treatment Programs: Guidance From Research , 2002, Science & practice perspectives.

[45]  L. Hedges,et al.  A Meta‐analysis of the Effect of HIV Prevention Interventions on the Sex Behaviors of Drug Users in the United States , 2002, Journal of acquired immune deficiency syndromes.

[46]  R. Grant,et al.  Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. , 2002 .

[47]  W. Ling,et al.  A screening trial of amantadine as a medication for cocaine dependence. , 2002, Drug and alcohol dependence.

[48]  L. Najavits,et al.  Seeking safety: An evidence-based model for substance abuse and trauma/PTSD. , 2007 .

[49]  J. Fleishman,et al.  Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons , 2001, Journal of General Internal Medicine.

[50]  D. Urada,et al.  Meta-analysis of HIV risk-reduction interventions within drug abuse treatment programs. , 2001, Journal of consulting and clinical psychology.

[51]  M. Gwinn,et al.  Incidence of HIV among injection drug users entering drug treatment programs in four US cities , 2001, Journal of Urban Health.

[52]  C. Hopfer,et al.  Heroin use among adolescents in treatment for substance use disorders. , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.

[53]  A. Copeland,et al.  Drug abuse treatment as an HIV prevention strategy: a review. , 2000, Drug and alcohol dependence.

[54]  R. Chaisson,et al.  Highly Active Antiretroviral Therapy in a Large Urban Clinic: Risk Factors for Virologic Failure and Adverse Drug Reactions , 1999, Annals of Internal Medicine.

[55]  F Rhodes,et al.  Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group. , 1998, JAMA.

[56]  R. Booth,et al.  Effectiveness of HIV/AIDS interventions on drug use and needle risk behaviors for out-of-treatment injection drug users. , 1998, Journal of psychoactive drugs.

[57]  Nancy F. Hansen,et al.  The NIMH Multisite HIV Prevention Trial: reducing HIV sexual risk behavior. The National Institute of Mental Health (NIMH) Multisite HIV Prevention Trial Group. , 1998, Science.

[58]  G. Woody,et al.  Drug abuse treatment as AIDS prevention. , 1998, Public health reports.

[59]  Anke A. Ehrhardt,et al.  A Review of HIV Interventions for At-Risk Women , 1997, AIDS and Behavior.

[60]  N. El-Bassel,et al.  15-month followup of women methadone patients taught skills to reduce heterosexual HIV transmission. , 1992, Public health reports.

[61]  S. Schinke,et al.  Building skills of recovering women drug users to reduce heterosexual AIDS transmission. , 1991, Public health reports.

[62]  M. Stark,et al.  General and specific psychotherapy role induction with substance-abusing clients. , 1985, The International journal of the addictions.

[63]  Dongseok Choi,et al.  Reducing HIV-Related Risk Behaviors Among Injection Drug Users in Residential Detoxification , 2010, AIDS and Behavior.

[64]  P. Crits-Christoph,et al.  Reducing sex under the influence of drugs or alcohol for patients in substance abuse treatment. , 2010, Addiction.

[65]  R. Shouse,et al.  Late HIV testing - 34 states, 1996-2005. , 2009, MMWR. Morbidity and mortality weekly report.

[66]  M. Farrell,et al.  Substitution treatment of injecting opioid users for prevention of HIV infection. , 2004, The Cochrane database of systematic reviews.

[67]  K. Carroll,et al.  Addressing ethnic disparities in drug abuse treatment in the clinical trials network , 2007 .

[68]  N. Volkow,et al.  Stimulant-induced enhanced sexual desire as a potential contributing factor in HIV transmission. , 2007, The American journal of psychiatry.

[69]  M. Greenlick,et al.  Bridging the Gap between Practice and Research , 1998 .